Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 190149, 3 pages
Case Report

Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty

1Department of Cardiology, Van Region Training and Research Hospital, 65100 Van, Turkey
2Department of Cardiology, Pamukkale University, 20070 Denizli, Turkey
3Department of Hematology, Van Region Training and Research Hospital, 65100 Van, Turkey

Received 13 December 2013; Revised 20 January 2014; Accepted 5 February 2014; Published 10 March 2014

Academic Editor: Michael S. Firstenberg

Copyright © 2014 Mustafa Yurtdaş et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an incidence of 0.2% to 0.5%. We report the case of a 50-year-old man who developed thrombocytopenia after tirofiban use (both intracoronary and peripheral) over hours and the successful management of this complication after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.